At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
12 lead Electrocardiogramother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Philips HeartStart Intrepid 12-lead Electrocardiogram (ECG) Study - The ICE (Intrepid Clinical Engineering) Study
In Brief
A clinical study evaluating 12 lead Electrocardiogram for Sudden Cardiac Arrest. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The purpose of this research study is to collect clinical data to validate a software update for 12-lead electrocardiogram monitoring.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSudden Cardiac Arrest
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartOct 2022
Primary CompletionNov 2022
First PostedDec 2022
TodayJul 2026
First PostedDec 5, 2022
Enrollment StartOct 3, 2022
Primary CompletionNov 2, 2022
TodayJul 2, 2026
Enrollment to primary: 29 daysPosted 3.6 years ago
Interventions
12 lead Electrocardiogramother
12 lead Electrocardiogram